§ Funding Round
Series B funding round for Memo Therapeutics raising $25M in February 2022
Series B funding round for Memo Therapeutics raising $25M in February 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
Pureos Bioventures | — | — |
| Angel | andreas wüpper | |
| Organization | — | |
Swisscanto InvestLEAD | — | — |
| Organization | — | |
| Angel | christian schneider | |
| Organization | — | |
| Organization | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$97.9M
Top Valuation
-
Memo Therapeutics raised $25M in a Series B round.
The round was announced on 02/01/22.
The round was led by Swisscanto Invest, swiss federal office of public health.
